Searchable abstracts of presentations at key conferences in endocrinology

ea0010p48 | Neuroendocrinology and behaviour | SFE2005

Effect of third ventricle infusuion of ghrelin on plasma GH, T3 T4, milk amount and constituents in the dairy goats

Khazali H

The goal of this study was to determine whether ghrelin increase the mean plasma concentration of thyroxine (T4), triiodothyronine (T3), growth hormone (GH), milk amount and constituents in the dairy goats. Animals were anesthetized throughout the surgery for stereotaxic methods and jugular wein cannulations. Nine goats were randomly divide into 3 groups. Each group received daily infusion of either 1 or 2 or 4 ug gherlin for 7 days into their third ventricle. Blood samples we...

ea0009s48 | Clinical Management Workshop 4: Endocrine sequelae of childhood cancer | BES2005

Growth and puberty after treatment for intracranial neoplasia

Spoudeas H

Some 10-15% of the 1:1000 young adults who are cancer survivors, has survived a brain tumour. Increasing treatment efficacy and decreasing long-term disability are important human and economic aims.The growth failure of children with brain tumours is multifactorial. Cranial irradiation, blamed for late neurotoxicity, is increasingly substituted by chemotherapy, but the disease itself, surgery and adjuvant chemotherapy must contribute. Evolving irradiatio...

ea0008s26 | Neuroendocrine Tumours | SFE2004

New Genetic Causes of Pheochromocytoma

Neumann H

Pheochromocytoma can present as a sporadic or familial tumor. Classic syndromes include multiple endocrine neoplasia type 2 caused by mutations of the RET gene, Von Hippel-Lindau disease by mutations of the VHL gene and neurofibromatosis by mutations of the NF 1 gene. In 2000 for familial neck paraganglioma the susceptibility gene of succinatedehydrogenasis subunit D, SDHD was identified and subsequently also shown to be mutated in a subset of familial and sporadic pheochromoc...

ea0007s16 | Pituitary adenomas | BES2004

Clinical markers of aggressive behaviour in non-functioning pituitary adenomas

Turner H

Clinically non-functioning pituitary adenomas (NFA) are common anterior pituitary tumours, arising from a variety of pituitary cell types, but little is known of their pathogenesis. The vast majority of NFA are benign tumours; some of which may remain intrasellar, while others may exhibit expansive extrasellar growth and/or become invasive and infiltrate dura and bone. Pituitary carcinoma, defined as a tumour with subarachnoid, brain or systemic metastases is very rare. Determ...

ea0005s15 | Apoptosis/Survival Signalling | BES2003

Cell proliferation and death in endocrine glands: The corpus luteum paradigm

Fraser H

The corpus luteum (CL) is a dynamic but transient endocrine gland. Although proliferation of hormone-producing cells ceases after ovulation, proliferation of endothelial cells is intense and the CL becomes highly vascularised. However, unless the CL is rescued by pregnancy, all these cells will die. Investigation of cell death in the CL offers an opportunity to study the mechanisms underlying regulated death of parenchymal and endothelial cells. Apoptosis is extensive in the C...

ea0005s39 | HRT - The Good, the Bad and the Ugly | BES2003

HRT and fracture prevention

Jacobs H

With the recent publication of the results of randomised controlled trials (RCTs) of HRT we are at last developing the potential to assess the relative safety as well as the relative efficacy of preventative treatment. As detailed on the website of the Medicines Control Agency (www.mca.gov.uk), treatment with HRT is associated with an increased risk of cancer of the breast and ovary, of stroke and venous thromboembolism, together with an increased rate of surgery for gallstone...

ea0004p68 | Growth and development | SFE2002

Effect of GABA agonist on mean concentrations of growth hormone, thyroxine, triiodothyronine in the women

Khazali H

Effect of GABA agonist on mean concentrations of growth hormone, thyroxine, triiodothyronine in the womenH Khazali, University of Tarbiat Modarres, Tehran, IranThe goal of this study was to determine whether injections ofGABA agonist increase the plasma concentration of thyroxine (T4) ,triiodothyronine (T3)and growth hormone (GH) in the women. Subgects were randomly divide into 4 groups...

ea0003s22 | Metalloproteinases and Their Inhibitors: Regulators of Endocrine Activity | BES2002

The biology of matrix metalloproteinases and their inhibitors

Nagase H

Matrix metalloproteinases (MMPs) play critical roles in embryonic development, morphogenesis, blastocyst implantation, ovulation, post-partum uterine involution, endometrial cycling, bone remodelling and wound healing, and in diseases such as arthritis, cancer, cardiovascular diseases, tissue ulceration and fibrosis. Currently, twenty-four vertebrate MMPs have been reported. An important feature of the MMPs is that many of these genes are inducible by growth factors, cytokines...

ea0003p187 | Neuroendocrinology | BES2002

The effect of serotonin on the GH, T3, T4, milk production and composition

Khazali H

The goal of this study was to determine whether injections of serotonin increase the plasma concentration of thyroxine (T4) , triiodothyronine (T3), growth hormone (GH), milk amount and constituents in the cows. sixty cows were randomly divide into 4 groups. Each group received daily injections of either saline or 1, 2, 4 milligrams serotonin per Kg for 15 days. Blood samples were collected daily on day 3 before injections untill 3 days after the last injection . Samples were ...

ea0003p197 | Neuroendocrinology | BES2002

The effect of bombesin on the Gh, T3, T4 and milk production and compositions

Khazali H

The goal of this study was to determine whether injections of bombesin increase the plasma concentration of thyroxine (T4) , triiodothyronine (T3), growth hormone (GH), milk amount and constituents in the cows. sixty cows were randomly divide into 4 groups. Each group received daily injections of either saline or 1, 2, 4 milligrams bombesinper kilogram for 15 days. Blood samples were collected daily on day 3 before injections untill 3 days after the last injection . Samples we...